The C/EBPα-(PU.1- <i>LOUP</i> ) regulatory circuit regulates monocyte/macrophage development and immune functions

A A. S. M. Waliullah (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) T Thuy-An Nguyen (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) B Barbara Dziegielewska (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) J Junyan Zhang K Kevin Qiu (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) M Minh L. Tran (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) N Nicholas N. Nguyen (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) L Leran Wang (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) A Andrew Pan (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) M Malena Nong (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) N Natalie Segovia (1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA) Y Yaning Li Y Yanzhou Zhang S Simone Ummarino T Tuan M. Nguyen (2Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA) A Ani Manichaikul (Department of Genome Sciences, Center for Public Health Genomics, University of Virginia) P Preetam Ghosh G Golam Mohi (6Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA) A Adam N. Goldfarb (University of Virginia Health Sciences Center, Charlottesville, Virginia, United States) J Jeffrey W. Craig (Department of Pathology University of Virginia Medical Center Charlottesville Virginia USA) D Daniel G. Tenen B Bon Q. Trinh

Abstract

Abstract The myeloid transcription factors PU.1 and CCAAT/enhancer-binding protein α (C/EBPα) are essential for monocyte/macrophage (Mo/MΦ) development, and their dysregulation has been linked to myeloid malignancies and immune disorders. Although their binding to enhancers for myeloid coding genes is established, their control of noncoding regulatory RNAs remains poorly understood. Using a comprehensive collection of putative and verified enhancers, we profiled the PU.1 cistrome and transcriptome, identifying a subset of noncoding genes that are both associated with PU.1-bound enhancers and regulated by PU.1. Notably, PU.1 induces expression of LOUP, an enhancer RNA transcribed from a locus containing a conserved PU.1 cis-regulatory element cluster, which is characterized by features of myeloid-specific enhancers. Disruption of a PU.1-binding motif in the LOUP promoter and the enhancer reduced LOUP promoter activity, whereas mutation of another PU.1-binding site within the LOUP gene body and the enhancer, which modulates enhancer-promoter interaction, diminished both Pu.1 and Loup levels in mice. The myeloid transcription factor C/EBPα, which binds to the enhancer, is necessary for PU.1 and LOUP expression as inducible deletion of Cebpa in mice led to their downregulation. LOUP depletion impaired Mo/MΦ marker and inflammatory cytokine expression as well as phagocytic function. Collectively, our findings reveal that PU.1 and the enhancer RNA LOUP form a previously unrecognized feed-forward loop, induced by C/EBPα, that drives their mutual expression and establishes a regulatory circuit. This circuit programs monocyte to macrophage differentiation and innate immune function, providing important implications for inflammatory diseases and myeloid malignancies.

Article Details

Journal Blood
Volume / Issue Vol. 147, Issue 17
Published April 23, 2026
Pages 1970-1983
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (22)

A

A. S. M. Waliullah

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

T

Thuy-An Nguyen

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

B

Barbara Dziegielewska

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

J

Junyan Zhang

K

Kevin Qiu

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

M

Minh L. Tran

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

N

Nicholas N. Nguyen

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

L

Leran Wang

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

A

Andrew Pan

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

M

Malena Nong

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

N

Natalie Segovia

1Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA

Y

Yaning Li

Y

Yanzhou Zhang

S

Simone Ummarino

T

Tuan M. Nguyen

2Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA

A

Ani Manichaikul

Department of Genome Sciences, Center for Public Health Genomics, University of Virginia

P

Preetam Ghosh

G

Golam Mohi

6Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA

A

Adam N. Goldfarb

University of Virginia Health Sciences Center, Charlottesville, Virginia, United States

J

Jeffrey W. Craig

Department of Pathology University of Virginia Medical Center Charlottesville Virginia USA

D

Daniel G. Tenen

B

Bon Q. Trinh